A Phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia (CLL)

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - July 6, 2016 Category: Hematology Authors: Ian W. Flinn, Amy S. Ruppert, William Harwin, David Waterhouse, Steven Papish, Jeffrey A Jones, John Hainsworth, John C. Byrd Tags: Research Article Source Type: research